Federal Register / Vol. 66, No. 81 / Thursday, April 26, 2001 / Notices 20997

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[Document Identifier: HCFA–R–197]

Agency Information Collection

Activities: Proposed Collection;

Comment Request

AGENCY: Health Care Financing

Administration, HHS.

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, is publishing the

following summary of proposed

collections for public comment.

Interested persons are invited to send

comments regarding this burden

estimate or any other aspect of this

collection of information, including any

of the following subjects: (1) The

necessity and utility of the proposed

information collection for the proper

performance of the agency’s functions;

(2) the accuracy of the estimated

burden; (3) ways to enhance the quality,

utility, and clarity of the information to

be collected; and (4) the use of

automated collection techniques or

other forms of information technology to

minimize the information collection

burden.

Type of Information Collection

Request: Revision of a currently

approved collection.

Title of Information Collection:

Maximizing the Effective Use of

Telemedicine: A Study of the Effects,

Cost Effectiveness and Utilization

Patterns of Consultations via

Telemedicine.

Form No.: HCFA–R–197 (OMB#

0938–0705).

Use: This study deals with several

issues of importance to HCFA regarding

the recent proliferation of Telemedicine

programs. The primary goal of this

study is to develop policy

recommendations for Medicare

concerning utilization review and

payment methods for Telemedicine

services. The major objective is to

evaluate the use of interactive video

Telemedicine consultation.

Recommendations will be based on

analysis of the use of Telemedicine for

such medical consultation.

Frequency: Other: periodically.

Affected Public: Individuals or

households, Business or other for-profit,

and Not-for-profit institutions.

Number of Respondents: 1,823.

Total Annual Responses: 92,803.

Total Annual Hours: 415.

To obtain copies of the supporting

statement and any related forms for the

proposed paperwork collections

referenced above, access HCFA’s Web

Site address at http://www.hcfa.gov/

regs/prdact95.htm, or E-mail your

request, including your address, phone

number, OMB number, and HCFA

document identifier, to

Paperwork@hcfa.gov, or call the Reports

Clearance Office on (410) 786–1326.

Written comments and

recommendations for the proposed

information collections must be mailed

within 60 days of this notice directly to

the HCFA Paperwork Clearance Officer

designated at the following address:

HCFA, Office of Information Services,

Security and Standards Group, Division

of HCFA Enterprise Standards,

Attention: Dawn Willinghan, HCFA–R–

197, Room N2–14–26, 7500 Security

Boulevard, Baltimore, Maryland 21244–

1850.

Dated: April 20, 2001.

Julie Boughn,

Director, HCFA Office of Information

Services, Security and Standards Group,

Division of HCFA Enterprise Standards.

[FR Doc. 01–10422 Filed 4–25–01; 8:45 am]

BILLING CODE 4120–03–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[Document Identifier: HCFA–1561]

Agency Information Collection

Activities: Submission for OMB

Review; Comment Request

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, has submitted to the

Office of Management and Budget

(OMB) the following proposal for the

collection of information. Interested

persons are invited to send comments

regarding the burden estimate or any

other aspect of this collection of

information, including any of the

following subjects: (1) The necessity and

utility of the proposed information

collection for the proper performance of

the agency’s functions; (2) the accuracy

of the estimated burden; (3) ways to

enhance the quality, utility, and clarity

of the information to be collected; and

(4) the use of automated collection

techniques or other forms of information

technology to minimize the information

collection burden.

Type of Information Collection

Request: New Collection.

Title of Information Collection: Health

Insurance Benefit Agreement and

Supporting Regulations in 42 CFR part

489.

Form No.: HCFA–1561 (OMB# 0938–

NEW).

Use: Applicants to the Medicare

program are required to agree to provide

services in accordance with Federal

requirements. The HCFA–1561 is

essential for HCFA to ensure that

applicants are in compliance with the

requirements. Applicants will be

required to sign the completed form and

provide operational information to

HCFA to assure that they continue to

meet the requirements after approval.

Frequency: Other: as needed.

Affected Public: Business or other forprofit, not-for-profit institutions, and

State, Local or Tribal Government.

Number of Respondents: 3,000.

Total Annual Responses: 3,000.

Total Annual Hours: 150.

To obtain copies of the supporting

statement for the proposed paperwork

collections referenced above, access

HCFA’s web site address at http://

www.hcfa.gov/regs/prdact95.htm, or Email your request, including your

address and phone number, to

Paperwork@hcfa.gov, or call the Reports

Clearance Office on (410) 786–1326.

Written comments and

recommendations for the proposed

information collections must be mailed

within 30 days of this notice directly to

the OMB Desk Officer designated at the

following address: OMB Human

Resources and Housing Branch;

Attention: Allison Eydt; New Executive

Office Building, Room 10235;

Washington, DC 20503.

Dated: April 4, 2001.

John P. Burke III,

HCFA Reports Clearance Officer, HCFA,

Office of Information Services, Security and

Standards Group, Division of HCFA

Enterprise Standards.

[FR Doc. 01–10421 Filed 4–25–01; 8:45 am]

BILLING CODE 4120–03–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[HCFA–3056–NC]

Medicare Program; Evaluation Criteria

and Standards for Peer Review

Organization 6th Round Contract

AGENCY: Health Care Financing

Administration (HCFA), HHS.

ACTION: Notice with Comment Period.

SUMMARY: This notice describes how

HCFA intends to evaluate the Peer

20998 Federal Register / Vol. 66, No. 81 / Thursday, April 26, 2001 / Notices

Review Organizations (PROs) under

their 6th round contracts, for efficiency

and effectiveness in accordance with the

Social Security Act. In accordance with

the provisions of the Government

Performance and Results Act of 1993,

Tasks 1 and 4 of the 6th round contracts

with the Peer Review Organizations are

performance based.

DATES: Comments will be considered if

we receive them at the appropriate

address, as provided below, no later

than 5 p.m. on June 25, 2001.

ADDRESSES: Mail written comments (1

original and 3 copies) to the following

address: Health Care Financing

Administration, Department of Health

and Human Services, Attention: HCFA–

3056–NC, P.O. Box 8013, Baltimore, MD

21244.

If you prefer, you may deliver your

written comments (1 original and 3

copies) to one of the following

addresses: Room 443–G, Hubert

Humphrey Building, 200 Independence

Avenue, SW., Washington, DC 20201–

0001, or Room C5–16–03, 7500 Security

Boulevard, Baltimore, MD 21244–1850.

Because of staffing and resource

limitations, we cannot accept comments

by facsimile (FAX) transmission. In

commenting, please refer to file code

HCFA–3056–NC. Comments received

timely will be available for public

inspection as they are received,

generally beginning approximately 3

weeks after publication of a document,

in Room 443–G of the Department’s

offices at 200 Independence Avenue,

SW., Washington, DC 20201–0001, on

Monday through Friday of each week

from 8:30 a.m. to 5 p.m. (Telephone

(202) 690–7890).

FOR FURTHER INFORMATION CONTACT:

Susan Smith, (410) 786–6748.

SUPPLEMENTARY INFORMATION:

I. Background

The Peer Review Improvement Act of

1982 (Title I, Subtitle C of Public Law

97–248) amended Part B of Title XI of

the Social Security Act (the Act) to

establish the Peer Review Organization

(PRO) program. The PRO program was

established to redirect, simplify and

enhance the cost-effectiveness and

efficiency of the medical peer review

process. Sections 1152, 1153(b) and

1153(c) of the Act define the types of

organizations eligible to become PROs

and establish certain limitations and

priorities regarding PRO contracting. In

42 CFR 462.102 and 462.104, (Medicare

and Medicaid Programs; Programs of

All-Inclusive Care for the Elderly, 64 FR

66234 (November 24, 1999) (To be

recodified at CFR Part 475) subpart C, of

our regulations, we describe the types of

organizations eligible to become PROs

and the capabilities they must

demonstrate.

The Secretary enters into contracts

with PROs to perform three broad

functions:

• Improve quality of care for

beneficiaries by ensuring that

beneficiary care meets professionally

recognized standards of health care.

• Protect the integrity of the Medicare

Trust Fund by ensuring that Medicare

only pays for services and items that are

reasonable and medically necessary and

that are provided in the most

economical setting.

• Protect beneficiaries by

expeditiously addressing individual

cases such as beneficiary quality of care

complaints, contested hospital issued

notices of noncoverage (HINNs), alleged

Emergency Medical Treatment and

Labor Act (EMTALA) violations (patient

dumping), and other statutory

responsibilities.

Section 1154 of the Act requires that

PROs review those services furnished by

physicians; other health care

practitioners; and institutional and noninstitutional providers of health care

services, including health maintenance

organizations and competitive medical

plans; as specified in their contracts

with the Secretary.

Section 1153(h)(2) of the Act requires

the Secretary to publish in the Federal

Register the general criteria and

standards that will be used to evaluate

the efficient and effective performance

of contract obligations by PROs and to

provide the opportunity for public

comment. The following criteria apply

to PROs operating under the 6th Round

contracts. The PRO 6th Round contracts

were awarded for 3 years with starting

dates staggered into three approximately

equal groups starting August 1, 1999,

November 1, 1999 and February 1, 2000.

II. Measuring PRO Performance

Under the 6th Round contract, PROs

are responsible for completing Tasks in

the following 5 areas:

Task 1—National Quality Improvement

Projects.

Task 2—Local Quality Improvement

Projects.

Task 3—Quality Improvement Projects

in Conjunction with Medicare+Choice

Plans.

Task 4—Payment Error Prevention.

Task 5—Other Mandatory Activities.

The PRO must meet the performance

standards for each of these 5 Tasks to be

eligible for a noncompetitive renewal

for the 7th Round contract cycle, except

that a PRO with no M+C organization in

its state will not be evaluated on Task

3. However, meeting the minimum

performance standards does not

guarantee a noncompetitive renewal of

its contract. (If, for example, an

organization within a particular State

meeting the definition of a PRO

expresses an interest in competing for a

contract currently held by a PRO from

outside that State, pursuant to § 1153(i)

we will compete the contract despite

acceptable performance by the current

PRO.) We will make a final decision on

renewal/nonrenewal by the end of the

30th month of the 6th Round contract.

We will issue a ‘‘Notice of Intent to

Non-renew the PRO Contract’’ letter to

all PROs that do not meet the minimum

performance standards no later than the

end of the 33rd month of the contract.

The PRO will be considered to have met

minimum performance standards if the

PRO has demonstrated acceptable

performance in each Task area as

specified in section III, (Standards for

Minimum Performance) of this notice.

If the initial quantitative and/or

qualitative assessments suggest that the

PRO has not met or exceeded the

criteria for one or more of the five Tasks,

its performance of that Task(s) will be

referred to a HCFA-wide panel for a

second, more in-depth assessment of its

contract performance. The panel will be

made up of representatives from each of

the 4 PRO Regional Offices and the

Central Office. The panel will have the

right to create its own procedures, but

must apply them consistently to all

PROs it reviews. At a minimum, the

panel will use the criteria listed below

for all Tasks:

• The degree of collaboration the PRO

exhibited with other PROs, both by

sharing the lessons and tools it

developed and by adopting practices

and tools developed by other PROs.

• Whether the PRO was a new

contractor for the 6th round contract.

• Whether specific identifiable

circumstances uniquely interfered with

the PRO’s improvement efforts.

• Any other issues which the panel

may deem relevant.

Additionally, for Tasks 1 and 4, the

panel will consider the degree of

difference between the measured

improvement of the PRO and that of the

top 75 percent of the PROs in the same

contract renewal cycle.

III. Standards for Minimum

Performance General Criteria

In general, Task 1 and portions of

Tasks 3 and 4 will be evaluated

quantitatively. Success will be

measured by assessing changes in

statewide baselines over a period of

time. Task 2 and the remaining portions

of Tasks 3 and 4 will be qualitatively

Federal Register / Vol. 66, No. 81 / Thursday, April 26, 2001 / Notices 20999

evaluated. Success will be measured

both on the improvement achieved and

on the contribution made to the health

care quality improvement process. Task

5 will be evaluated based on evidence

reported by the PRO that demonstrates

that it has met the requirements

contained in Parts 4, 5, 7, 9 and 12 of

the PRO Manual for the mandatory

activities. A principal evaluation

element for all Tasks will be the

timeliness and completeness of all

required reports.

Task-Specific Standards

1. Task 1 National Quality Improvement

Projects

We provided the PRO a state-specific

baseline combined topic average (CTA)

near the start of the 6th round contract.

We calculated the CTA by including all

the quality indicators for the six

national topics. We will provide the

PRO a second state-specific CTA based

on re-measurement data, in time for an

end-of-contract evaluation.

The baseline and remeasurement

CTAs are calculated in 2 steps. First, for

national topics with multiple Quality

Indicators (QIs), each QI has been given

a specific weight for calculating

performance on that topic. Using these

weights, an average, termed a Topic

Weighted Average, is created for each

topic. Then a Combined Topic Average

(CTA) is calculated. The CTA is then

calculated by using the average of the 6

National Topic Weighted Averages. The

success of the PRO’s efforts under this

task will be evaluated on the basis of the

observed improvement in the second

CTA compared to the baseline CTA.

The PRO’s relative improvement on

the CTA will be compared to the

relative improvement demonstrated by

the other PROs that share the same

contract renewal cycle. For the purposes

of this evaluation, relative improvement

is defined as the amount of observed

improvement compared to a possible

100% improvement.

If the PRO has demonstrated some

measured improvement on the CTA and

its relative improvement exceeds at least

25 percent of the other PROs in the

same contract renewal cycle, it shall be

judged to have performed successfully

on Task 1.

If the PRO fails to demonstrate any

measured improvement on the CTA or

its relative improvement is less than at

least 75 percent of the other PROs in the

same contract renewal cycle, our

evaluation panel will review its work

under Task 1.

2. Task 2 Local Quality Improvement

Projects

We will evaluate the success of the

PRO’s work under Task 2 in two ways.

In most instances, we will assess

whether the PRO has achieved

measurable improvement on the quality

indicators, particularly when the

projects have employed project tools

and indicators that have previously

been well-developed. In the event that

a project fails to achieve measurable

improvement, we will use as a second

standard of success the amount of

knowledge that has been gained through

the experience of the project. We

directly acknowledge that projects using

new tools and indicators may not

always achieve measurable

improvement. We will consider these

projects successful only if the PRO bases

the project(s) on plausible hypotheses,

uses scientifically valid project and

evaluation methods, and clearly

documents all essential elements of the

project. The PRO must document these

lessons learned in a professional

manner comparable to the standards

used by peer-reviewed journals.

3. Task 3 Quality Improvement Projects

in Conjunction With Medicare+Choice

Plans

The PRO shall report on all projects

in which it collaborates with one or

more M+C plans under Task 3 using the

SDPS reporting system. The PRO’s

success under Task 3 will be evaluated

in one of two ways. For HCFA-directed

projects that all plans implement using

a standardized set of indicators, such as

diabetes, we will evaluate the PRO in a

manner comparable to the evaluation

criteria in Task 1.

For all other projects in which the

PRO collaborates with the plan(s) or

provides technical assistance to the

plan(s), we will evaluate the success of

the PRO in a manner comparable to the

evaluation criteria in Task 2.

We may also solicit feedback from the

plans on their satisfaction with the

PRO’s technical assistance, and may

also consider this information as part of

its evaluation of the PRO’s success

under Task 3.

4. Task 4 Payment Error Prevention

We provided the PRO a statewide

baseline payment error rate and will

provide a second statewide payment

error rate in time for an end-of-contract

performance evaluation. For the

purposes of this contract, we will define

the inpatient PPS payment error rate as

the number of dollars found to be paid

in error out of the total of all dollars

paid for inpatient PPS services. The

number of dollars paid in error is

defined as the absolute (unsigned)

difference between what was actually

paid and what should have been paid as

a result of review.

The PRO’s relative improvement on

the state-wide payment error rate will be

compared to the relative improvement

demonstrated by the other PROs that

share the same contract renewal cycle.

For the purposes of this evaluation,

relative improvement is defined as the

amount of observed improvement,

compared to the amount of possible

improvement, that is, zero payment

errors.

The success of the PRO’s efforts under

Task 4 will be evaluated, in part, based

on the observed improvement in the

second statewide payment error rate

compared to the baseline payment error

rate.

The PRO’s efforts under Task 4 will

be determined to be successful if it—

1. Performs the required first year

projects within the agreed time frames;

2. Establishes contact and

coordination with local, State and

Federal agencies, contractors, hospitals,

medical staffs and their professional and

trade associations, and pertinent law

enforcement agencies (Evaluation of this

requirement will be based upon reports

from the agencies identified by the

Project Officer.); and

3. Demonstrates some measured

improvement on the statewide payment

error rate, and its relative improvement

exceeds at least 25 percent of the other

PROs in the same contract renewal

cycle.

If the PRO does not meet

requirements 1 and 2 or if it fails to

demonstrate any measured

improvement on the statewide payment

error rate or its relative improvement is

less than at least 75 percent of the other

PROs in the same contract renewal

cycle, our evaluation panel will review

its work under Task 4.

5. Task 5 Other Mandatory Activities

The Project Officer will continuously

review the work of the PRO under Task

5, based primarily on periodic reports

that the PRO shall submit through the

SDPS reporting system. The PRO’s work

will be judged to have been successful

for each of the categories of review and

other mandated activities only if it

conducts the work in accordance with

the requirements set forth in Parts 4, 5,

7, 9 and 12 of the PRO Manual.

In accordance with the provisions of

Executive Order 12866, this notice with

comment period was not reviewed by

the Office of Management and Budget.

Authority: Section 1153 of the Social

Security Act (42 U.S.C. 1320c–2)

21000 Federal Register / Vol. 66, No. 81 / Thursday, April 26, 2001 / Notices

(Catalog of Federal Domestic Assistance

Program No. 93.778, Medical Assistance

Program; No. 93.773, Medicare-Hospital

Insurance Program; and No. 93.774,

Medicare—Supplementary Medical

Insurance Program)

Dated: February 27, 2001.

Michael McMullan,

Acting Deputy Administrator, Health Care

Financing Administration.

[FR Doc. 01–10397 Filed 4–25–01; 8:45 am]

BILLING CODE 4120–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Center for Research

Resources; Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Center for

Research Resources Special Emphasis Panel

General Clinical Research Centers.

Date: June 20–21, 2001.

Time: June 20, 2001, 5:00 p.m. to

Adjournment.

Agenda: To review and evaluate grant

applications.

Place: Hilton Garden Inn, Philadelphia

Center City, 1100 Arch Street, Philadelphia,

PA 19107.

Contact Person: D.G. Patel, PhD, Scientific

Review Administrator, Office of Review,

National Center for Research Resources,

National Institutes of Health, 6705 Rockledge

Drive, Room 6018, Bethesda, MD 20892–

7965, (301) 435–0824, dgpatel@ncrr.nih.gov.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.306, Comparative Medicine,

93.306; 93.333, Clinical Research, 93.333;

93.371, Biomedical Technology; 93.389,

Research Infrastructure, National Institutes of

Health, HHS)

Dated: April 20, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–10362 Filed 4–25–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Meeting

Pursuant to section 10(a) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the Sleep

Disorders Research Advisory Board.

The meeting will be open to the

public, with attendance limited to space

available. Individuals who plan to

attend and need special assistance, such

as sign language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

Name of Committee: Sleep Disorders

Research Advisory Board.

Date: June 26, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To discuss sleep research and

education priorities and programs.

Place: National Institutes of Health,

Natcher Building 45, Conference Room D,

9000 Rockville Pike, Bethesda, MD 20892.

Contact Person: Carl E. Hunt, MD, Director,

National Center on Sleep Disorders Research,

National Heart, Lung, and Blood Institute,

National Institutes of Health, 6701 Rockledge

Drive, Room 10138, Bethesda, MD 20892,

301/435–0199, huntc@nhlbi.nih.gov.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.233, National Center for

Sleep Disorders Research; 93.837, Heart and

Vascular Disease Research; 93.838, Lung

Diseases Research; 93.839, Blood Diseases

and Resources Research, National Institutes

of Health, HHS)

Dated: April 20, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–10365 Filed 4–25–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Arthritis and

Musculoskeletal and Skin Diseases;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Arthritis and Musculoskeletal and Skin

Diseases Special Emphasis Panel.

Date: May 8, 2001.

Time: 1:00 p.m. to 3:00 p.m.

Agenda: To review and evaluate grant

applications and/or proposals.

Place: Natcher Building, 45 Center Drive,

Conference Rooms E1/E2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Tracy A. Shahan, PhD,

Scientific Review Administrator, NIH/

NIAMS, Bethesda, MD 20892, (301) 594–

4952.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.846, Arthritis,

Musculoskeletal and Skin Diseases Research,

National Institutes of Health, HHS)

Dated: April 20, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–10351 Filed 4–25–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Arthritis and

Musculoskeletal and Skin Diseases;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Arthritis and Musculoskeletal and Skin

Diseases Special Emphasis Panel.

Date: May 8, 2001.

Time: 8:00 a.m. to 5:00 p.m.

Agenda: To review and evaluate grant

applications.